According to a report from P&S Market Research, North America holds the largest share in the global 3D bioprinting market, which was valued at almost $100 million in 2015. The global market is expected grow at a CAGR of 35.9% between 2016 and 2022.
The medical sector and its millions of patients suffering from a major problem: there is a massive imbalance between the number of people waiting for critical organ transplants and the number of donated organs actually available. Simply put, the lack of available organs means that more patients are dying than could otherwise be the case. This state of affairs, though troublesome in and of itself, has provided a huge incentive for scientists in the 3D bioprinting industry, many of whom are working on ways to create 3D printed tissue and 3D printed human organs which could someday be used for transplantation, easing the burden on the donor system and potentially saving millions of lives.
Read the full article here: http://www.3ders.org//articles/20161111-3d-bioprinting-market-dominated-by-north-america-expected-to-grow-at-cagr-of-359.html